Senegal becomes first African country to locally manufacture generic sickle cell treatment

Senegalese company produces first Africa-made treatment for sickle cell disease.

Senegal has become the first African country to locally manufacture a generic sickle cell treatment, DREPAF, a hydroxyurea-based medicine.